삼중음성 유방암 환자 유래 이식편 모델에서 에리불린과 코판리십 병용 평가 보충 그림 S3

Guo 등(수요)이 이 질문을 연구했다.

www.synapsesocial.com/papers/68e660cfb6db6435875eed39 — DOI: https://doi.org/10.1158/2767-9764.25976510.v1

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Supplementary Figure S3 from Evaluation of Copanlisib in Combination with Eribulin in Triple-negative Breast Cancer Patient-derived Xenograft Models· 2024
2. Supplementary Figure S1 from Evaluation of Copanlisib in Combination with Eribulin in Triple-negative Breast Cancer Patient-derived Xenograft Models· 2024
3. Supplementary Figure S1 from Evaluation of Copanlisib in Combination with Eribulin in Triple-negative Breast Cancer Patient-derived Xenograft Models· 2024
4. Supplementary Figure S4 from Evaluation of Copanlisib in Combination with Eribulin in Triple-negative Breast Cancer Patient-derived Xenograft Models· 2024
5. Supplementary Figure S4 from Evaluation of Copanlisib in Combination with Eribulin in Triple-negative Breast Cancer Patient-derived Xenograft Models· 2024